Mark Christianson, Business Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), sold 15,616 shares at $0.74 ($12K) on 2026-03-30, disclosed to the SEC on 2026-04-01.
Seasonal sale ($12k) by Business Development Director — this insider has traded NMTC in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.74 | 15,363 | $11K | 98.3% |
| 2 | $0.78 | 253 | $197 | 1.7% |
| Total | $0.74 avg | 15,616 | $12K | 100% |
| Filing → |
| NMTC | SELL | 2026-03-12 | $11K | — | Filing → |
| NMTC | SELL | 2025-09-09 | $22K | — | Filing → |
| NMTC | SELL | 2025-06-05 | $6K | — | Filing → |